QTTB Latest Headlines

Q32 Bio spotlights Week 36 hair-regrowth data and a 16-week off-drug durability signal for bempikibart

Market Chameleon (Wed, 30-Sep 9:40 AM)

Q32 Bio spotlights Week 36 hair regrowth and a 16-week off-drug durability signal for bempikibart in alopecia areata

Market Chameleon (Wed, 30-Sep 9:19 AM)

Q32 Bio Raises $200 Million in Public Offering to Accelerate Autoimmune Drug Development

Market Chameleon (Wed, 15-Jul 7:06 AM)

QTTB Anticipates Pivotal Clinical Data Release for Alopecia Areata as Stock Activity Surges

Market Chameleon (Mon, 13-Jul 9:51 AM)

QTTB’s Bempikibart Delivers Promising 36-Week Results in Alopecia Areata—Safety Profile and Efficacy Stand Out

Market Chameleon (Mon, 13-Jul 7:05 AM)